investors header image

Future of mass/crowd fever screening and detection

Our patented technology integrates existing hardware with software and AI to transform fever screening tests, including COVID-19 and enable mass and crowd screenings in real time to identify febrile individuals. Further, this integrates perfectly with automated/AI analytics of video and image streams

The best part is, each screening takes less than 3 seconds and utilizes existing IR body temperature camera systems to provide fever identification. This technology categorizes normal, hot and febrile individuals as three distinct groups with 99% accuracy; or more precisely, specificities above 99.7%, sensitivities of 98%, and precisions of around 89%

Better accuracy than COVID-19 testing, and it works for all pathogens

Image for investors displaying our technology
Portal layout and content

The Challenge

No solution exists to quickly screen individuals for contagious disease infections. By the time an individual recognizes an infection, they have been infected, contagious and spreading the virus for several days. Globally, epidemics cost over $500B a year (Prior to COVID-19)

Our Solution

Fever is one of the first symptoms to develop. Fevers typically occur in almost all cases of infection in 24 – 48 hours. Initial fevers are almost never perceived; however, our technology can detect these febrile individuals immediately, in less than 5 seconds

Market Opportunity

The US alone provides a $40B market opportunity for this technology that spans over 500,000 businesses of 40 employees or more in office and manufacturing; 10,000 airports, stations, ports and 20,000 commercial planes, trains and ships; 100,000 schools & universities; 100,000 hospitals, doctors’ offices and care-homes; 10,000 sports and concert arenas; 200,000 churches and places of worship, and over 5,000 military bases

Competitive Advantage

Our technology is simple enough to explain in less than 5 minutes, with no medical background required. We have over 30 years of thermal physiological expertise and 25 years of temperature measurement and thermal imaging. Our patent prepared and managed by one of the leading IP legal firms in the US. This simple, but inventive concept ensures patent claims are very strong and difficult to compromise. After an extensive search, no relevant prior art or blocking technologies have been identified.

All solutions and product content
Portal image for investors demonstrating our API

Product Range

Solutions are available in a portfolio of products. Our portfolio offers a full range of solutions; Screen-Portal, is a flexible API or portal that accepts image and video streams from all standard packet protocols. Screen-as-a-Service, consists of managed and hosted SaaS solutions, while Screen-Fully-Managed provides a full platform that includes site audits, camera, calibration, server hardware and fully deployed & managed portals

Additionally, our technology is simply ported to existing integrated screening and scanning platforms, as well as being easily embedded directly into camera and imager hardware